How do epinephrine and norepinephrine differ as neurotransmitters regarding their central actions, receptor preferences, and physiological effects?

Epinephrine vs. Norepinephrine as Neurotransmitters: Key Differences

Epinephrine is a much more powerful cardiac stimulant than norepinephrine, with substantially greater β-adrenergic effects, while norepinephrine has higher affinity for α-receptors and functions primarily as a neurotransmitter rather than a hormone 1, 2.

Receptor Preferences and Binding Affinity

The fundamental distinction lies in their receptor selectivity:

• Norepinephrine has high affinity for α-receptors (both α1 and α2) and β1-receptors, but minimal β2-receptor activity 2, 3. This makes it predominantly a noradrenergic neurotransmitter with strong vasoconstrictive properties 4.

• Epinephrine stimulates all subtypes of α and β adrenoreceptors (α1, α2, β1, β2, and β3) with high affinity 2, 5, 6. This broader receptor activation profile classifies it as both a neurotransmitter and hormone 4.

The research evidence suggests that β2- and α2-adrenergic receptors preferentially respond to epinephrine (the hormone), while β1- and α1-receptors preferentially respond to norepinephrine (the neurotransmitter) 4.

Central vs. Peripheral Actions

Norepinephrine

• Released from sympathetic nerve endings by exocytosis, with only a small proportion reaching systemic circulation 7
• Functions primarily as the neurotransmitter of the sympathetic noradrenergic system (SNS) 8
• Circulating norepinephrine mirrors whole-body sympathetic activity when measured in systemic venous plasma 7
• Predominantly located postsynaptically in sympathetic terminal junctions 4

Epinephrine

• Derived from sympathetic (preganglionic) stimulation of the adrenal medulla 7
• Circulating epinephrine reflects the degree of sympathetic activation of the adrenal medulla 7
• Functions as the main hormone secreted by adrenomedullary chromaffin cells 8
• Predominantly acts on extrajunctional and presynaptic receptors (α2 and β2) 4

Physiological and Cardiovascular Effects

Cardiac Effects

Epinephrine produces dramatically more potent cardiac stimulation 1:

• Accelerates heart rate significantly
• Improves cardiac conduction
• Stimulates rate of relaxation
• Reinforces systolic efficiency
• Increases cardiac output substantially
• Cost: Dramatic increase in cardiac work and oxygen consumption 1
• Higher risk of tachycardia and arrhythmias compared to norepinephrine 1

Norepinephrine has more modest cardiac effects 1:

• Direct positive chronotropic effects are counterbalanced by vagal reflex activity from increased blood pressure 1
• Increases stroke volume and coronary blood flow via β2-receptor stimulation 1
• Effects on cardiac function and cardiac output are inconsistent and time-dependent 1
• Produces less tachycardia than epinephrine 2

Vascular Effects

Norepinephrine 2, 3:

• Primarily increases systemic vascular resistance through α-receptor activation
• Used to increase blood pressure in conditions with reduced systemic vascular resistance (e.g., septic shock)
• May reduce end-organ perfusion due to vasoconstriction 2

Epinephrine 5:

• Three-fold mechanism for blood pressure elevation: direct myocardial stimulation, increased heart rate, and peripheral vasoconstriction
• At low doses, β2-mediated vasodilation decreases systemic vascular resistance and diastolic blood pressure
• At higher doses, α1-mediated peripheral vasoconstriction predominates 5
• Constricts most vascular beds including renal, splanchnic, mucosal, and skin 5

Metabolic Effects

Epinephrine has more pronounced metabolic actions 5:

• Increases glycogenolysis
• Reduces glucose uptake by tissues
• Inhibits insulin release in the pancreas
• Results in hyperglycemia and increased blood lactic acid 5

Pharmacokinetic Differences

Both catecholamines share similar rapid clearance profiles:

• Epinephrine: Effective half-life <5 minutes, pharmacokinetic steady state achieved within 10-15 minutes 5
• Norepinephrine: Plasma concentration falls with mean half-time of 2.4 ± 0.7 minutes, metabolic clearance rate of 3,070 ± 200 ml/min 9

Both are extensively metabolized by monoamine oxidase and catechol-O-methyltransferase, primarily in the liver, kidneys, and extraneuronal tissues 5.

Clinical Implications

When Norepinephrine is Preferred

• First-line vasopressor in septic shock 10
• Situations requiring increased systemic vascular resistance without excessive cardiac stimulation 2
• When minimizing risk of tachyarrhythmias is priority 1, 10
• Recent evidence suggests lower mortality and re-arrest rates in post-cardiac arrest shock compared to epinephrine 11, 12, 13

When Epinephrine is Indicated

• First-aid treatment of anaphylaxis (medication of choice) 14
• Cardiogenic shock when dobutamine refractoriness is present and blood pressure remains low 2
• When more potent cardiac stimulation is required 1
• Life-threatening hypotension requiring immediate vasopressor support 2

Critical Caveat

Plasma norepinephrine concentrations exceeding 1,800 pg/ml are required to produce hemodynamic or metabolic effects 9. Under usual conditions, norepinephrine's biologic actions are attributed only to its sympathetic neurotransmitter function. However, during exercise or major acute illness, norepinephrine levels may exceed this threshold, allowing it to function as both neurotransmitter and hormone 9.